Concepedia

Author

Mark Hardink

Pfizer (United States)ORCID

Also Known As

M.A. Hardink, Mark A. Hardink, Mark Hardink

10

Publications

371

Citations

7

H-Index

29

Concepts

All Affiliations

Pfizer (United States)
MH

About

Mark Hardink is an author at Pfizer (United States) specializing in medicine, analytical chemistry, and engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

94

2

Engineering

3

3

235

3

Biomolecular Engineering

3

3

225

4

Biochemistry

2

2

36

5

Natural Sciences

1

1

15

Mark Hardink

×

6

Publications

281

Citations

6

H-Index

YearCitations

Carbonyldiimidazole-Mediated Lossen Rearrangement

Pascal Dubé, Noah F. Fine Nathel, Michael G. Vetelino,

Organic Letters

2009

177

On the method development of immobilized polysaccharide chiral stationary phases in supercritical fluid chromatography using an extended range of modifiers

James Lee, J.T. Lee, William L. Watts,

Journal of Chromatography A

2014

33

Process analytical technology (PAT): applications to flow processes for active pharmaceutical ingredient (API) development

Courtney Talicska, Eamon C. O'Connell, Howard W. Ward,

Reaction Chemistry & Engineering

2022

25

Chromatographic resolution of atropisomers for toxicity and biotransformation studies in pharmaceutical research

Tony Q. Yan, Frank Riley, Laurence Philippe,

Journal of Chromatography A

2015

21

Synthesis of Nirmatrelvir: Development of an Efficient, Scalable Process to Generate the Western Fragment

Russell F. Algera, Christophe Allais, Aaron F. Baldwin,

Organic Process Research & Development

2023

15

Evolution of strategies to achieve baseline separation of ten anionic, water-soluble sulfated estrogens via achiral packed column supercritical fluid chromatography

M.A. Patel, Mark Hardink, L. Wrisely,

Journal of Chromatography A

2014

10

Page 1